Anti-Human CD40 Therapeutic Antibody (Dacetuzumab)

Recombinant monoclonal antibody to CD40. Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.
Supplier Creative Biolabs
Product # TAB-152
Pricing Inquiry
Host Mouse
Target CD40
Species Reactivity Human
Type IgG1
Applications IF, IP, Neut, FuncS, ELISA, FC, ICC, Agonist, Cyt, WB
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback